Avatar 1Avatar 2Avatar 3Avatar 4Avatar 5

Earn 10$ Cash for every Pro+ Friend you Refer!

Ascendis Pharma AS

Ascendis Pharma AS

ASND · NASDAQ
ASND · NASDAQ

Next Earnings: 11 Nov 2026

225.68
USD-5.29-2.29%

Latest News

    @MarketRebels
    MarketRebels

    STARTS NOW Rebel's Edge 🏴‍☠️ 1pm CME Fed Tool swings to 61% Chance of 50 bps cut. China's economy showing signs of strain. #UOA in $ORCL $AAPL $ASND $NUVL with @MXLESQ Sports 🏈 @petenajarian NFL: Early poor start for great teamsRavens 0-2, Cinci 0-2... why? https://t.co/qlnNHGky8b

      Seeking Alpha

      ASND, GDS, ADSK and CDZI among after hours movers

      Analysts Recommendations

      Bullish

      Buy

      Strong Buy

      Buy

      Hold

      Sell

      Strong Sell

      Day Range

      224.26USD
      230.43USD

      52 Week Range

      186.05USD
      282.15USD

      Market Cap

      15.18BUSD

      lock-imagelock-image

      Get Full Access with Profit PRO

      See which Billionaires own this investment

      About

      General Information

      Type

      Common Stock

      Exchange

      NASDAQ

      Currency Code

      USD

      Currency Name

      US Dollar

      Country Name

      USA

      Country ISO

      US

      ISIN

      DK0060615755

      CUSIP

      04351P101

      Sector

      Healthcare

      Industry

      Biotechnology

      Fiscal Year End

      December

      IPO date

      -

      Updated At

      -

      Highlights

      PE Ratio

      17.63

      PEG Ratio

      -

      Book Value

      24.89

      Dividend Share

      -

      Dividend Yield

      -

      Earnings Share

      12.8

      Wall Street Target Price

      310.26

      EPS Estimate Current Year

      12.79

      EPS Estimate Next Year

      9.62

      EPS Estimate Current Quarter

      0.7667

      EPS Estimate Next Quarter

      1.3167

      Most Recent Quarter

      -

      Profitability

      Revenue TTM

      1,047,020,032

      Gross Profit TTM

      955,894,976

      EBITDA

      263,454,000

      Profit Margin

      70.85%

      Return On Assets TTM

      9.58%

      Return On Equity TTM

      118.78%

      Revenue Per Share TTM

      16.889

      Qtly Revenue Growth YOY

      114.70%

      Diluted Eps TTM

      12.8

      Qtly Earnings Growth YOY

      0.00%

      Valuation

      Trailing PE

      17.63

      Forward PE

      19

      Price Sales TTM

      14.1743

      Price Book MRQ

      8.9131

      Enterprise Value Revenue

      11

      Enterprise Value EBITDA

      65

      Peers analysis

      • Revolution Medicines Inc
        RVMDRevolution Medicines Inc

        205.88

        3.03%
      • UCB SA ADR
        UCBJYUCB SA ADR

        122.52

        1.52%
      • Moderna Inc
        MRNAModerna Inc

        197.82

        1.30%
      • Vertex Pharmaceuticals Inc
        VRTXVertex Pharmaceuticals Inc

        527.40

        0.95%
      • argenx SE
        ARGNFargenx SE

        1010.26

        0.00%
      • CSL Limited
        CMXHFCSL Limited

        121.55

        -5.41%
      • UCB SA
        UCBJFUCB SA

        235.66

        -3.37%
      • Regeneron Pharmaceuticals Inc
        REGNRegeneron Pharmaceuticals Inc

        788.04

        -0.96%
      • CSL Ltd
        CSLLYCSL Ltd

        31.24

        -0.64%
      • argenx NV ADR
        ARGXargenx NV ADR

        959.49

        -0.18%
      XM

      Trade Stocks with $30 Free + Double your Deposits with a 100% Bonus

      Trade with a Trusted, Award-Winning Broker.

      Trading involves risk. The value of investments may go up or down. Trade responsibly.

      FAQs

      What is Ascendis Pharma AS stock price today?

      What is Ascendis Pharma AS stock ticker?

      Is ASND stock price going up?

      What is the analyst recommendation for ASND?

      What is ASND market cap?

      Does ASND release financial reports?

      When is ASND next earnings date?

      What were ASND Earnings for the last quarter?

      What was ASND Revenue for the last quarter?

      What was ASND Net Income for the last quarter?

      Does ASND pay dividends?

      How many employees does ASND have?

      What is ASND EBITDA?

      How to buy ASND stocks?

      Should I invest in ASND stock?

      What are you waiting for?Get started today
      ©
       2026 
      All rights reserved

      Profit.com is operated by Darqube Ltd, registered in England and Wales under company number 12197411.

      Profit.com is an educational, subscription-based software platform providing financial market analytics and simulated trading using real-time market data and virtual funds. All trading activity on the platform is simulated. No real capital is used, no customer deposits are collected, and no real-money trades are executed or facilitated.

      Profit.com is not a broker and does not provide brokerage, investment, or other financial services or investment advice. All content, tools and features are provided for educational and informational purposes only. Simulated trading results are hypothetical and are not indicative of actual or future results. The terms “trading” and “trader” refer exclusively to simulated activity on Profit.com and should not be interpreted as real-money trading or investing.